HIV trials recruiting in New York

All HIV trials nationally

Cities in New York

Recruiting trials in New York

• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · New York: The Bronx
• A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
  NCT07392372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York, Rochester
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Manhasset
• A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
  NCT06736613 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Commack, Harrison, New York, Rockville Centre
• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
  NCT07143968 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · New York: Stony Brook, Syracuse
• A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
  NCT07569029 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · New York: New York, Rochester
• Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
  NCT06648629 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: Syracuse
• An Effectiveness Trial of the PrEP for WINGS Study
  NCT06853314 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: New York
• Antiviral Clinical Trial for Long Covid-19
  NCT06511063 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
  NCT06206564 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Blood Collection Biorepository for Liver Disease Research
  NCT03025074 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · New York: Buffalo
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · New York: New York
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
  NCT06796686 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · New York: New York
• Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
  NCT07390474 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · New York: New York, Rochester
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
  NCT06307977 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: Male · New York: New York
• Ending the Epidemic Interventions in the Dental Setting - UH3
  NCT06890988 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Queens
• Ending the HIV Epidemic: An All-facility Intervention for Patient and Healthcare Staff Well-being
  NCT05785169 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Expanding HOPE Liver
  NCT07778459 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Feasibility of Internet-based HIV Prevention Research
  NCT07625917 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: The Bronx
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, The Bronx
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · New York: New York, The Bronx
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
  NCT06263426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · New York: New York
• MyPEEPS LITE Trial
  NCT06741631 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 29 Years · Sex: Male · New York: New York
• MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
  NCT06741618 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 25 Years · Sex: Male · New York: New York
• Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
  NCT05929911 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: The Bronx
• P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention
  NCT06785376 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: Male · New York: New York
• Persuasive Health Communication Intervention for HIV/HCV
  NCT05968573 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Project I Test: Implementing HIV Testing in Opioid Treatment Programs
  NCT03135886 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Stick2PrEP Cisgender Women and Trans Individuals
  NCT05165745 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Study of GS-0415 and How It Works in People With HIV
  NCT07719491 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: The Bronx
• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
  NCT07040319 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 45 Years · Sex: Female · New York: Stony Brook, The Bronx
• The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
  NCT05652088 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• The TAIL-PrEP Study
  NCT06868641 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
  NCT05642715 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 79 Years · Sex: All (male and female) · New York: The Bronx
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · New York: The Bronx
• Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
  NCT06598397 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · New York: Stony Brook, The Bronx
• Virtual Reality (VR) Self-Hypnosis Software
  NCT06398847 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York